A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-Small Cell Lung Cancer
Purpose: Mutation of the Kirsten ras sarcoma viral oncogene homolog (KRAS) and loss of p53 function are commonly seen in patients with non-small cell lung cancer (NSCLC). Combining therapeutics targeting these tumor-defensive pathways with cisplatin in a single-nanoparticle platform are rarely devel...
Main Authors: | Gu, Li (Author), Deng, Zhou J. (Author), Roy, Sweta (Author), Hammond, Paula T (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research (AACR),
2021-04-27T19:46:05Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer
by: Lawrence B. Mensah, et al.
Published: (2019-05-01) -
Osteotropic Therapy via Targeted Layer-by-Layer Nanoparticles
by: Morton, Stephen Winford, et al.
Published: (2014) -
Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles
by: Xinglong Fan, et al.
Published: (2021-09-01) -
Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
by: Hong Y, et al.
Published: (2020-06-01) -
Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
by: Dienemann Hendrik, et al.
Published: (2007-05-01)